The Toxicity and Benefit of Various Dosing Strategies for Interleukin-2 in Metastatic Melanoma and Renal Cell Carcinoma

Interleukin-2 (IL-2) therapy has been used with success in curing meta­static renal cell carcinoma and melanoma in a small minority of patients. However, the benefits can be accompanied by severe toxicity. This review of the literature discusses varying doses of IL-2 and their associated re­sponse r...

Descripción completa

Detalles Bibliográficos
Autores principales: Pachella, Laura A., Madsen, Lydia T., Dains, Joyce E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625627/
https://www.ncbi.nlm.nih.gov/pubmed/26557408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625627/
https://www.ncbi.nlm.nih.gov/pubmed/26557408

Ejemplares similares